The effect of a wound care solution containing polyhexanide and betaine on bacterial counts: Results of an in vitro study

Ostomy Wound Management

Volumn 58, Issue 10, 2012, Pages 32-36

  Minnich, Kevin E ^a   Stolarick, Rebecca ^a   Wilkins, Robert G ^b   Chilson, Gary ^b   Pritt, Stacy L ^c   Unverdorben, Martin ^a  

^a B Braun Medical Inc   (United States)

^b Moog Medical Devices Group   (United States)

^c Biological Test Center   (United States)

Author keywords

Antimicrobial agent; Betaine; In vitro study; Polyhexanide; Wounds

Indexed keywords

BETAINE; BIGUANIDE DERIVATIVE; POLY(HEXAMETHYLENEBIGUANIDE);

ARTICLE; BACTERIAL COUNT; HUMAN; IN VITRO STUDY; INJURY; MICROBIOLOGY;

BETAINE; BIGUANIDES; COLONY COUNT, MICROBIAL; HUMANS; WOUNDS AND INJURIES;

EID: 84867775058     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Pecoraro RE, Rodeheaver G, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994;130(4):489-493. (Pubitemid 24123372)
2. Franz MG, Robson MC, Steed DL, Barbul A, Brem, H, Cooper DM, et al. Guidelines to aid healing of acute wounds by decreasing impediments to healing. Wound Repair Regen. 2008;16:723-748.
3. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis. 2004;17:91-96. (Pubitemid 38453386)
4. Gottrup F, Apelqvist J, European Wound Management Association Patient Outcome Group, Price P. Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management. J Wound Care. 2010;19:237-268.
5. Nagoba BS, Wadher BJ, Rao AK, Kore GD, Gomashe AV, Ingle AB. A simple and effective approach for the treatment of chronic wound infections caused by multiple antibiotic resistant Escherichia coli. J Hosp Infect. 2006;69:177-180.
6. Robson MC. Wound infection - a failure of wound healing caused by an imbalance of bacteria. Surg Clin N Am. 1997;77:637-650. (Pubitemid 27256038)
7. Warriner R, Burrell R. Infection and chronic wound: a focus on silver. Adv Skin Wound Care. 2005:18:2-12.
8. Vandenbulcke K, Horvat LIL, De Mil M, Slegers G, Beel H. Evaluation of the antibacterial activity and toxicity of two new hydrogels: a pilot study. Int J Lower Extremity Wounds. 2006;5(2):109-114. (Pubitemid 43726041)
9. Chu CC, Williams DF. Effects of physical configuration and chemical suture of suture materials on bacterial adhesion: a possible link to wound infection. Am J Surg. 1984;147:197-204. (Pubitemid 14186632)
10. Baron EJ, Peterson LR, Finegold SM. Laboratory methods for detection of antibacterial resistance. In: Diagnostic Microbiology, 11th ed. London, UK: Mosby;2002:229-250.
11. Schmit-Neuerburg KP, Bettag C, Schlickewei W, Fabry W, Hanke J, Renzing- Kohler K, et al. [Effectiveness of an improved antiseptic in treatment of contaminated soft tissue wounds]. Chirurg. 2001;72:61-71. (Pubitemid 33681889)
12. Valenzuela AR, Perucho NS. [The effectiveness of a 0.1% polyhexanide gel]. Rev Enferm. 2008;31:7-12.
13. Andriessen A, Eberlein T. Assessment of a wound cleansing solution in the treatment of problem wounds. WOUNDS. 2008;20:171-175.
14. Kaehn K, Eberlein T. In-vitro test for comparing the efficacy of wound rinsing solutions. Br J Nurs. 2009;18(11):S4-S10.
15. Rose F, Swain G. Bisguanides having antibacterial activity. J Chem Soc. 1956;850:4422-4425.
16. Davies A, Bentley M, Field BS. Comparison of the action of vantocil, cetrimide and chlorhexidine on Escherichia coli and its spheroplasts and the protoplasts of Gram-positive bacteria. J Appl Bacteriol. 1968;31:448-461.
17. Ikeda T, Tazuke S, Bamford C, Ledwith A. Spectroscopic studies on the interaction of polymeric in-chain biguanide biocide with phospholipic membranes as probed by 8-anilinonaphthalene-1-sulphonate. Bull Chem Soc Jpn. 1985;58:705-709.
18. Kaehn K. Polihexanide: a safe and highly effective biocide. Skin Pharmacol Physiol. 2010;23(suppl):7-16.
19. Domsch A. Chemistry and application of undecylenic acid and derivatives thereof for cosmetics. SÖFW-Journal. 1994;120:322-329.
20. Müller G, Koburger T, Jethon FUW, Kramer A. Comparison of the bactericidal efficacy and in vitro cytotoxicity of Lavasept® and Prontosan®. GMS Krankenhaushygiene Interdisziplinär. 2007;2(2):1-11.
21. United States Pharmacopeia, National Formulary (USP 32- NF 27) <51> Antimicrobial Effectiveness Testing. The United States Pharmacopeial Convention. 2009(1):67-69.
22. Lass-Florl C, Perkhofer S. In vitro susceptibility-testing in Aspergillus species. Mycoses. 2008;51:437-446.
23. Brahm H, Segal BH. Aspergillosis. New Engl J Med. 2009;360(18):1870- 1884.
24. Kramer A, Roth B, Müller G, Rudolph P, Klöcker N. Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol Physiol. 2004;17(3):141-146. (Pubitemid 38478889)
25. Horrocks A. Prontosan wound irrigation and gel: management of chronic wounds. Br J Nurs. 2006-2007;15(22):1222-1228.
26. Romanelli M, Dini V, Barbanera S, Bertone MS. Evaluation of the efficacy and tolerability of a solution containing propyl betaine and polyhexanide for wound irrigation. Skin Pharmacol Physiol. 2010;23(suppl):41-44.